TY  - JOUR
AU  - Brown, Helen
AU  - Vansteenkiste, Johan
AU  - Nakagawa, Kazuhiko
AU  - Cobo, Manuel
AU  - John, Thomas
AU  - Barker, Craig
AU  - Kohlmann, Alexander
AU  - Todd, Alexander
AU  - Saggese, Matilde
AU  - Chmielecki, Juliann
AU  - Markovets, Aleksandra
AU  - Scott, Marietta
AU  - Ramalingam, Suresh S
PY  - 2019
DO  - 10.1016/j.jtho.2019.09.009
UR  - http://hdl.handle.net/10668/14645
T2  - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
AB  - EGFR mutated (EGFRm) NSCLC tumors occasionally express programmed cell death ligand 1 (PD-L1), although frequency and clinical relevance are not fully characterized. We report PD-L1 expression in patients with EGFRm advanced NSCLC and association with...
LA  - en
PB  - Elsevier
KW  - EGFR mutated
KW  - FLAURA
KW  - NSCLC
KW  - Osimertinib
KW  - Programmed death ligand 1
KW  - Acrylamides
KW  - Aniline Compounds
KW  - Antineoplastic Agents
KW  - Apoptosis
KW  - B7-H1 Antigen
KW  - ErbB Receptors
KW  - Humans
KW  - Ligands
KW  - Lung Neoplasms
KW  - Mutation
TI  - Programmed Cell Death Ligand 1 Expression in Untreated EGFR Mutated Advanced NSCLC and Response to Osimertinib Versus Comparator in FLAURA.
TY  - research article
VL  - 15
ER  -